HuGE Literature Finder
Records
1
-
30
| Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC psychiatry 2021 Feb 21 (1): 70. Lu Jinjun, Yang Ye, Lu Jian, Wang Zuqing, He Yiping, Yan Yeliang, Fu Kai, Jiang Wenjuan, Xu Yunqing, Wu Renrong, Liu Wenqing, Zhao Jingpi |
| Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations. Progress in neuro-psychopharmacology & biological psychiatry 2021 Jan 109 110241. Ma Lingyue, Xiang Qian, Zhao Nan, Hu Changqing, Fang Meng, Tan Yunlong, Chen Song, Wang Zining, Liu Pinglan, Sun Kaoxiang, Li Youxin, Wu Fuxi, Tian Hongjun, Fang Maosheng, Zhao Xia, Wang Gang, Cui Yim |
| Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Jan 133 111087. Zubiaur Pablo, Soria-Chacartegui Paula, Koller Dora, Navares-Gómez Marcos, Ochoa Dolores, Almenara Susana, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Villapalos-García Gonzalo, Román Manuel, Martín-Vílchez Samuel, Abad-Santos Francis |
| Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia. NPJ schizophrenia 2021 Jan 7 (1): 5. Shin Wonsuk, Bang Minji, Kim Anhye, Cho Doo-Yeoun, Lee Sang-Hy |
| ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone. Progress in neuro-psychopharmacology & biological psychiatry 2020 Jul 110042. Ganoci Lana, Trkulja Vladimir, Živkovic Maja, Božina Tamara, Šagud Marina, Lovric Mila, Božina Na |
| Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia. Archives of medical research 2020 Feb 51 (1): 13-20. Zakharyan Roksana, Ghazaryan Hovsep, Kocourkova Lenka, Chavushyan Andranik, Mkrtchyan Artur, Zizkova Veronika, Arakelyan Arsen, Petrek Mart |
| Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity. The pharmacogenomics journal 2019 Oct . Lesche Dorothea, Mostafa Sam, Everall Ian, Pantelis Christos, Bousman Chad |
| Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects. Therapeutic drug monitoring 2019 Aug . Miroshnichenko Igor I, Pozhidaev Ivan V, Ivanova Svetlana A, Baymeeva Natalia |
| Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients. Irish journal of medical science 2019 Feb . Gradinaru Raluca, Andreescu Nicoleta, Nussbaum Laura, Suciu Liana, Puiu Mar |
| Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2018 Dec 1-53. Djordjevic Natasa, Radmanovic Branimir, Cukic Jelena, Baskic Dejan, Djukic-Dejanovic Slavica, Milovanovic Dragan, Aklillu Ele |
| The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study). Psychiatria Danubina 2018 Jun 30 (2): 157-163. Kurylev Alexey A, Brodyansky Vadim M, Andreev Boris V, Kibitov Alexander O, Limankin Oleg V, Mosolov Sergey |
| Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia. Journal of clinical pharmacology 2018 Jan 58 (1): 74-80. Ishigooka Jun, Iwashita Shuichi, Higashi Koushi, Liew Ei Leen, Tadori Yoshihi |
| ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Human psychopharmacology 2017 Dec . Papazisis Georgios, Goulas Antonios, Sarrigiannidis Alexios, Bargiota Stavroula, Antoniadis Diomidis, Raikos Nikolaos, Basgiouraki Emmanouela, Bozikas Vasileios P, Garyfallos Georgi |
| Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients. Translational psychiatry 2017 Jul 7 (7): e1170. Shi Y, Li M, Song C, Xu Q, Huo R, Shen L, Xing Q, Cui D, Li W, Zhao J, He L, Qin |
| Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India. Asian journal of psychiatry 2017 Jul 29 174-182. Kaur Gurjit, Gupta Deepti, Chavan Bir Singh, Sinhmar Vikas, Prasad Rajendra, Tripathi Adarsh, Garg P D, Gupta Rajiv, Khurana Hitesh, Gautam Shiv, Margoob Mushtaq Ahmed, Aneja Jitend |
| Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics. The international journal of neuropsychopharmacology 2017 Mar . Tóth Katalin, Csukly Gábor, Sirok Dávid, Belic Ales, Kiss Ádám, Háfra Edit, Déri Máté, Menus Ádám, Bitter István, Monostory Katal |
| CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia. Schizophrenia research 2017 Jan . Zeng Lei, Kang ChuanYuan, Yuan Jing, Zhang Yan, Wei YuJun, Xu Li, Zhou Fang, Yang JianZho |
| Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms. Annals of clinical biochemistry 2016 Dec . Akamine Yumiko, Sugawara-Kikuchi Yuka, Uno Tsukasa, Shimizu Tetsuo, Miura Masato |
| Influences of CYP2D610 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis. Acta pharmacologica Sinica 2016 Sep . Pei Qi, Huang Lu, Huang Jie, Gu Jing-Kai, Kuang Yun, Zuo Xiao-Cong, Ding Jun-Jie, Tan Hong-Yi, Guo Cheng-Xian, Liu Shi-Kun, Yang Guo-Pi |
| CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects. Bulletin of experimental biology and medicine 2016 Mar 160 (5): 687-90. Ivanova S A, Filipenko M L, Vyalova N M, Voronina E N, Pozhidaev I V, Osmanova D Z, Ivanov M V, Fedorenko O Yu, Semke A V, Bokhan N |
| Population pharmacokinetics of aripiprazole in healthy Korean subjects. International journal of clinical pharmacology and therapeutics 2016 Feb . Jeon Ji-Young, Chae Soo-Wan, Kim Min-G |
| Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics. Journal of clinical psychopharmacology 2015 Oct . Hwang Tzung-Jeng, Lo Wei-Ming, Chan Hung-Yu, Lin Ching-Feng, Hsieh Ming H, Liu Chen-Chun, Liu Chih-Min, Hwu Hai-Gwo, Kuo Ching-Hua, Chen Wei |
| Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. The pharmacogenomics journal 2015 Aug . Xu Q, Wu X, Li M, Huang H, Minica C, Yi Z, Wang G, Shen L, Xing Q, Shi Y, He L, Qin |
| Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment. Schizophrenia research 2015 Aug . van de Bilt M T, Prado C M, Ojopi E P B, Sousa R T, Loch A A, Zanetti M V, Talib L L, Gattaz W |
| Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia. Therapeutic drug monitoring 2014 Dec 36 (6): 815-8. Nakamura Akifumi, Mihara Kazuo, Nemoto Kenji, Nagai Goyo, Kagawa Shoko, Suzuki Takeshi, Kondo Tsuyos |
| Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia. The pharmacogenomics journal 2014 Oct 14 (5): 452-6. Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Inoue Y, Someya |
| Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. Therapeutic drug monitoring 2014 Oct 36 (5): 651-5. Suzuki Takeshi, Mihara Kazuo, Nakamura Akifumi, Kagawa Shoko, Nagai Goyo, Nemoto Kenji, Kondo Tsuyos |
| Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? Journal of psychopharmacology (Oxford, England) 2014 Mar 28 (7): 665-670. Koola Maju M, Tsapakis Evangelia M, Wright Padraig, Smith Shubulade, Kerwin Rip Robert W, Nugent Katie L, Aitchison Katherine |
| Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2014 55 (3): 877-84. Nussbaum Laura Alexandra, Dumitra?cu Victor, Tudor Anca, Gr?dinaru Raluca, Andreescu Nicoleta, Puiu Mar |
| A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia. Indian journal of psychological medicine 0 40 (4): 335-342. Chavan Bir S, Kaur Gurjit, Gupta Deepti, Aneja Jitend |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: